期刊文献+

心衰合并左束支传导阻滞患者与脑钠肽相关性的研究

下载PDF
导出
摘要 目的探讨心衰合并左束支传导阻滞(left bundle-branch block,LBBB)患者脑钠肽(BNP检测结果与心衰不合并LBBB患者脑钠肽(BNP)检查结果是否存在差异。方法选取2017年1月—2018年6月本院收治的30例心衰合并LBBB患者为观察组,另选取同期本院收治的30例心衰不合并LBBB患者为对照组,两组患者入院后均立即实施血浆BNP检测,对比两组血浆BNP检测数值。结果观察组的血浆BNP水平高于对照组(P<0.05)。结论心衰患者合并LBBB时与BNP检测结果存在一定的相关性,可以考虑LBBB是加重心衰患者死亡的一个影响因素。
出处 《齐齐哈尔医学院学报》 2019年第9期1093-1094,共2页 Journal of Qiqihar Medical University
基金 佛山市科学技术局科研立项(2014AB00304)
  • 相关文献

参考文献4

二级参考文献38

  • 1黄水明,方玉才,钱健,邢小中.B型钠尿肽检测对心力衰竭的早期诊断价值[J].心脑血管病防治,2005,5(1):32-34. 被引量:7
  • 2杨丽霞,祝善俊,孟素荣,鲁云敏,张晓燕.充血性心力衰竭病人血浆内皮素与肺动脉高压[J].中华心血管病杂志,1994,22(2):122-124. 被引量:25
  • 3Mosterd A,HoesA. Clinical epidemiology of heart failure[J]. Br Med J,2007,93 (9): 1137-46.
  • 4JENNY AD,PAUL PG,EVA P,et al. A systematic review of the diagnostic accuracy of natriuretic peptides for heart failure[J]. Arch Intem Med,2004,164(18): 1978-84.
  • 5McMcrry JJ,Adamopoulos S,Anker SD,et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012[J]. Eur J Heart Fail,2012,14(8):803-69.
  • 6Sudoh T,Kangawa K,Minamino N,et al. A neunatriuretie peptide in norcine brain[J]. Nature.1988.332(61591:78-81.
  • 7Maisel A. B-type natrluretic peptide levels: a potential novel "withe Count" for congestive heart failure[J]. J Card Fail,2001,7(2):183-93.
  • 8NDREPEPA G, BRAUN S, MEHILLI J, et al. Accuracy of N-terminal probrain natriuretic peptide to predict mortality or detect acute isehemia in patients with coronary artery disease [ J ]. Cardiology, 2008, 109 ( 4 ) : 249-257.
  • 9DICKSTEIN K, COHEN-SOLAL A, FILIPPATOS G, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 : the task force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC ( HFA ) and endorsed by the European Society of Intensive Care Medicine (ESICM) [ J]. Eur Heart J, 2008,29 ( 19 ) : 2388- 2442.
  • 10JUG B,SALOBIR BG,VENE N, et al. Interleukin-6 is a stronger prognostic predictor than high-sensitive C-reactive protein in patients with chronic stable heart failure[J]. Heart Vessels,2009,24(4) :271-276.

共引文献174

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部